4
Changes in Ownership
Hepion Pharmaceuticals, Inc. Filed Acc 0001104659-17-044100
Chief Executive Officer acquired 141,061 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
SAPIRSTEIN JAMES · Chief Executive Officer
Table I: Non-derivative
1 line| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2017-07-06 | Grant or award : show line 1 in the form | +141,061 | 170,727 | D |
Loading xslF345X03/a4.xml…